Search

everythinglearnresearchcommunity

for

Search:↓

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Female hair loss linked to metabolic syndrome, not in males.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The healthcare for transgender veterans could be better with a more unified team approach.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

American men are older, more obese, and have longer infertility than Canadian men.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Men are getting more beard transplants to look better and follow fashion trends.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Makeover TV shows promote unrealistic beauty standards and pressure women to conform to societal ideals.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Arab hair is generally thicker but less dense compared to other ethnicities, affecting hair disorder diagnosis and treatment.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.